ND/Purdue University Graduate Symposium

The first annual ND/Purdue University Graduate Symposium in Medicinal Chemistry and Chemical Biology was held from October 28-29, 2022 at the Morris Inn at the University of Notre Dame. This was a two-day student-organized symposium that will rotate annually between participating schools. The graduate students from the host university organized and moderated the entire meeting. The event brought together ~150 graduate students, post-doctoral fellows, and faculty members in the field of medicinal chemistry and drug discovery from the two universities. This event allowed students the opportunity to present their research to both peers and experienced researchers. Friday night included dinner and a presentation by keynote speaker, Dr. Dale Boger, from The Scripps Research Institute. Friday night concluded with a poster session presented by 30 graduate students and post-doctoral from two universities. Saturday events included a continental breakfast followed by eight oral presentations from both graduate students and post-doctoral fellows. Organizers from the University of Notre Dame were Hao Xu from the Blagg Lab and Amy Sorge from the Melander Lab. The event will be held next year at Purdue University, West Lafayette, IN.  Below are the poster session and oral presentation winners.…

Read More

Warren Center Talks

The Warren Center has introduced the Warren Center Lecture Series on the first Thursday of each month during the academic year. These talks showcase two PI's from the Warren Center. Each speaker will have 20 minutes to present and ~ 5-10 minutes for Q & A. There is a reception for about 30 minutes before and 30 minutes after both presentations. We hope these lectures will increase our knowledge and lead to new collaborative opportunities. The inaugural talk was held on Thursday, May 5, 2022.  Below is the schedule for the 2022-2023 academic year.…

Read More

Dr. Sanket Mishra wins BioCrossroads New 23 Pair Award

Sanket Mishra

Congratulations to Dr. Sanket Mishra, a former member of the Blagg lab, who was awarded the BioCrossroads new 23 Pair Award. The 23 Pair (Promising Achievers in Innovation and Research)  is a new recognition program that will celebrate and promote the state’s next generation of life sciences leaders. 23 Pair BioCrossroads advances Indiana’s signature strengths in the life sciences by connecting with corporate, academic and philanthropic partners; facilitating investments in promising start-ups; building new enterprises; and educating through conferences, reports and market development knowledge.  …

Read More

Sean Cocchia Rare Disease Research Grant Opportunity

Sean Cocchia Rare Disease Research Grant Opportunity

 

Applications due April 1, 2021.

 

 

Thanks to a gift from a benefactor, Sean Cocchia, we are offering one-time grants (up to $25,000) for research aimed at facilitating discoveries in rare disease research, which can include and is not limited to mechanistic studies, drug development, and/or related processes. The grants will provide financial support to conduct research during the 2020-2021 academic year. I ask that you disseminate this request for applications to members of your research team and other groups that you feel qualified to work in this area of research.

Read More

Leahy-Filipi Family Endowment for Excellence in Neuroscience Research

Leahy-Filipi Family Endowment for Excellence in Neuroscience Research

 

Funding is available through the Leahy-Filipi Family, Notre Dame alumni, to support research in neuroscience. This fellowship will provide a $10,000 fellowship. 

Overall Goals of Leahy Filipi Family Endowment for Excellence in Neuroscience  Research: 

Read More

WFCDD RFA Request for Applications-Now Open

The Warren Center for Drug Discovery invites new proposals for projects that are associated with drug discovery. In particular, projects associated with small molecule synthesis (libraries or molecular probes), hit validation, lead optimization, mid-sized scale up, assay development, protein purification, and ADMET screening. Any disease areas will be considered. Collaborative opportunities exist for the preparation of small molecules and/or computational-derived drug discovery via three cores: Chemical Synthesis & Drug Discovery, Computer-Aided Molecular Design, or Biological Screening and Development core. …

Read More

Welter Family Fellowship

Veronica Hubble, a graduate student in the Melander lab, is the first recipient of the Welter Family graduate fellowship for research on Cystic Fibrous. The Welter Family Fellowship in Science provides financial support to conduct research during the 2019 academic year. This fellowship is aimed at facilitating discoveries in cystic fibrosis research, which can include mechanistic studies, drug development, and/or related diseases that affect those with CF (eg. infections of the lung). Veronica’s proposal was entitled “Using small molecule adjuvants to combat antibiotic resistant bacteria in cystic fibrosis.”

Read More

Spring 2019 The Warren Roundup

As the 2018 academic year comes to an end, a summary of this year's accomplishments is provided in the annual Warren Roundup. First of all, several lead compounds have been identified by Notre Dame researchers and are undergoing preclinical evaluation, in hopes of identifying investigational new drugs (IND) for clinical evaluation.  …

Read More

Rare Disease Day 2017 and Rare Disease Research within the Warren Center

Rare Disease Day takes place annually on the last day of February. Its goal is to raise awareness amongst the general public and policy-makers. Global Genes maintains the RARE List™ of 7,000 rare diseases defined in the United States where a prevalence of less than 200,000 cases is the primary criteria. With about 25M Americans affected by a rare disease and the potential to increase our understanding of more common afflictions, rare disease research is a key to better health for all of us.…

Read More

Warren Family Center hosted a visitor from Novartis Pharmaceutical Corporation

Warren Family Center hosted a visitors from Novartis Pharmaceutical Corporation including Susan Giacalone (Area Scientific Associate Director- Field Medical MSL, Rare Diseases), Julio Fernandez (Field Medical National Director, Rare Diseases), John Murry, (Regional Scientific Director), Beth Ostergard Stillwell (Oncology Regional Scientific Director).…

Read More